How should mild chronic kidney disease (eGFR 60‑89 mL/min/1.73 m²) be managed peri‑operatively to minimize surgical risk?

Perioperative Management of Mild CKD (eGFR 60-89 mL/min/1.73 m²)

Patients with mild CKD (eGFR 60-89 mL/min/1.73 m²) undergoing elective surgery require specific perioperative precautions but do not face substantially increased short-term surgical risk compared to those with normal renal function, though vigilance for acute kidney injury is essential.

Risk Stratification

Mild CKD (eGFR 60-89 mL/min/1.73 m²) represents low to moderate risk in the KDIGO classification system 1. Recent evidence demonstrates that while these patients have increased risk of postoperative acute kidney injury (AKI), perioperative mortality and mid-term outcomes remain comparable to patients with normal renal function 2, 3.

• AKI risk: Increased by approximately 40% compared to normal renal function (26.1% vs 18.7% in CABG patients) 2
• Perioperative mortality: No significant difference from normal renal function 2
• Mid-term outcomes: No significant difference in 3-year mortality or major adverse cardiac events 2

Preoperative Optimization

Medication Management

Temporarily suspend RAAS antagonists (ACE inhibitors, ARBs, aldosterone antagonists) during the perioperative period 4:

• Discontinue before major surgery
• Hold during planned IV radiocontrast administration
• Hold during bowel preparation prior to colonoscopy
• Resume after hemostasis is achieved and patient is hemodynamically stable

Withdraw potentially nephrotoxic agents before and after procedures 4:

• NSAIDs
• Aminoglycosides
• Other nephrotoxic medications

Adjust drug dosing based on eGFR for renally-cleared medications 4.

Contrast Exposure Timing

If coronary angiography or contrast-enhanced imaging was performed preoperatively, delay elective surgery until the effect of radiographic contrast on renal function is assessed 5. This typically means waiting 48-96 hours and checking renal function before proceeding.

Intraoperative Management

Fluid Strategy

Administer adequate intravenous fluid aiming for +1 to +2 L positive balance by end of case 6:

• Avoid "zero-balance" strategies, which increase AKI risk
• Use isotonic crystalloids (0.9% saline or balanced solutions)
• Do not routinely use albumin or synthetic colloids (including hydroxyethyl starches) 6

Hemodynamic Goals

Maintain mean arterial pressure >60 mm Hg and adequate renal perfusion 5, 7:

• Use direct arterial pressure monitoring for major procedures
• Monitor intravascular volume status
• Avoid both hypovolemia and fluid overload

Anesthetic Considerations

• Maintain normocapnia and adequate oxygenation to preserve renal blood flow 7
• Avoid prolonged hypotension
• Consider goal-directed fluid therapy for high-risk procedures

Contrast-Related Procedures

For patients requiring intraoperative or perioperative contrast administration 4:

Mandatory interventions:

• Use lowest possible radiocontrast dose
• Avoid high-osmolar agents
• Adequate hydration with saline before, during, and after procedure:
  • 1 mL/kg/h 0.9% sodium chloride for 12 hours before and after (for elective procedures)
  • For urgent procedures: 3 mL/kg for 1 hour before, then 1 mL/kg/h for 6 hours after
• Withdraw nephrotoxic agents before and after
• Measure eGFR 48-96 hours after contrast exposure 4

Not recommended: Routine use of N-acetylcysteine or sodium bicarbonate (evidence inconsistent) 8.

Postoperative Monitoring

Renal Function Surveillance

Monitor serum creatinine and eGFR in the first 48-96 hours postoperatively 4:

• Daily creatinine for first 2-3 days
• Calculate eGFR to detect early AKI
• Persistent worsening of renal function (>10% decrease from baseline) carries significantly increased mortality risk (HR 7.3) 8

Medication Resumption

Resume RAAS antagonists once hemodynamically stable and adequate oral intake established 4:

• Check renal function and potassium within 1 week of restarting
• Do not routinely discontinue in mild CKD as they remain nephroprotective long-term

Resume oral anticoagulants after hemostasis is achieved 9.

Special Considerations

Bowel Preparation

Avoid oral phosphate-containing bowel preparations in patients with eGFR <60 mL/min/1.73 m² due to risk of phosphate nephropathy 4.

Cardiac Surgery

For patients undergoing CABG with mild renal dysfunction 5:

• Off-pump CABG may be reasonable to reduce AKI risk (though evidence is mixed)
• If on-pump, maintain hematocrit >19% and MAP >60 mm Hg
• Consider delaying surgery after angiography to assess contrast effect on renal function

High-Risk Surgery

For major vascular or abdominal surgery, mild CKD increases AKI risk but should not preclude necessary surgery 8. Focus on:

• Aggressive fluid management to maintain renal perfusion
• Avoidance of nephrotoxic agents
• Close postoperative monitoring

Common Pitfalls to Avoid

1. Do not use "zero-balance" fluid strategies – increases AKI risk 6
2. Do not routinely use colloids (albumin or HES) for volume replacement 6
3. Do not continue RAAS antagonists through surgery – temporarily suspend 4
4. Do not use phosphate-containing bowel prep – risk of acute phosphate nephropathy 4
5. Do not assume mild CKD is benign – still requires specific precautions despite similar mortality outcomes 2

The key distinction is that while mild CKD increases AKI risk, it does not substantially increase perioperative mortality when managed appropriately with adequate hydration, avoidance of nephrotoxins, and careful hemodynamic management 2, 3.